These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 15708673)

  • 1. Validation of a semi-automated human hepatocyte assay for the determination and prediction of intrinsic clearance in discovery.
    Reddy A; Heimbach T; Freiwald S; Smith D; Winters R; Michael S; Surendran N; Cai H
    J Pharm Biomed Anal; 2005 Feb; 37(2):319-26. PubMed ID: 15708673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A High Throughput, 384-Well, Semi-Automated, Hepatocyte Intrinsic Clearance Assay for Screening New Molecular Entities in Drug Discovery.
    Heinle L; Peterkin V; de Morais SM; Jenkins GJ; Badagnani I
    Comb Chem High Throughput Screen; 2015; 18(5):442-52. PubMed ID: 25828461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of an integrated in vitro-in silico PBPK (physiologically based pharmacokinetic) model to provide estimates of human bioavailability.
    Cai H; Stoner C; Reddy A; Freiwald S; Smith D; Winters R; Stankovic C; Surendran N
    Int J Pharm; 2006 Feb; 308(1-2):133-9. PubMed ID: 16352407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-content micronucleus assay in genotoxicity profiling: initial-stage development and some applications in the investigative/lead-finding studies in drug discovery.
    Mondal MS; Gabriels J; McGinnis C; Magnifico M; Marsilje TH; Urban L; Collis A; Bojanic D; Biller SA; Frieauff W; Martus HJ; Suter W; Bentley P
    Toxicol Sci; 2010 Nov; 118(1):71-85. PubMed ID: 20631060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated expressional analysis: application to the drug discovery process.
    Ilyin SE; Horowitz D; Belkowski SM; Xin H; Eckardt AJ; Darrow AL; Chen C; Maley D; D'Andrea M; Plata-Salamán CR; Derian CK
    Methods; 2005 Nov; 37(3):280-8. PubMed ID: 16308157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of the 96 well Caco-2 cell culture model for high throughput permeability assessment of discovery compounds.
    Marino AM; Yarde M; Patel H; Chong S; Balimane PV
    Int J Pharm; 2005 Jun; 297(1-2):235-41. PubMed ID: 15907606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cryopreserved human hepatocytes in suspension are a convenient high throughput tool for the prediction of metabolic clearance.
    Jouin D; Blanchard N; Alexandre E; Delobel F; David-Pierson P; Lavé T; Jaeck D; Richert L; Coassolo P
    Eur J Pharm Biopharm; 2006 Jul; 63(3):347-55. PubMed ID: 16621491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanistic insights from comparing intrinsic clearance values between human liver microsomes and hepatocytes to guide drug design.
    Di L; Keefer C; Scott DO; Strelevitz TJ; Chang G; Bi YA; Lai Y; Duckworth J; Fenner K; Troutman MD; Obach RS
    Eur J Med Chem; 2012 Nov; 57():441-8. PubMed ID: 22840492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High concordance of drug-induced human hepatotoxicity with in vitro cytotoxicity measured in a novel cell-based model using high content screening.
    O'Brien PJ; Irwin W; Diaz D; Howard-Cofield E; Krejsa CM; Slaughter MR; Gao B; Kaludercic N; Angeline A; Bernardi P; Brain P; Hougham C
    Arch Toxicol; 2006 Sep; 80(9):580-604. PubMed ID: 16598496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of sandwich-cultured rat hepatocytes to determine the intrinsic clearance of compounds with different extraction ratios: 7-ethoxycoumarin and warfarin.
    Treijtel N; van Helvoort H; Barendregt A; Blaauboer BJ; van Eijkeren JC
    Drug Metab Dispos; 2005 Sep; 33(9):1325-32. PubMed ID: 15951450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of a high-throughput absorption, distribution, metabolism, and excretion (ADME) system and results for 60 literature compounds.
    Yan Z; Lu C; Wu JT; Elvebak L; Brockman A
    Rapid Commun Mass Spectrom; 2005; 19(9):1191-9. PubMed ID: 15818724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cocktail of metabolic probes demonstrates the relevance of primary human hepatocyte cultures in a microfluidic biochip for pharmaceutical drug screening.
    Prot JM; Videau O; Brochot C; Legallais C; Bénech H; Leclerc E
    Int J Pharm; 2011 Apr; 408(1-2):67-75. PubMed ID: 21295126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of three human in vitro systems in the generation of major human excretory and circulating metabolites.
    Dalvie D; Obach RS; Kang P; Prakash C; Loi CM; Hurst S; Nedderman A; Goulet L; Smith E; Bu HZ; Smith DA
    Chem Res Toxicol; 2009 Feb; 22(2):357-68. PubMed ID: 19146377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of human pharmacokinetics--evaluation of methods for prediction of hepatic metabolic clearance.
    Fagerholm U
    J Pharm Pharmacol; 2007 Jun; 59(6):803-28. PubMed ID: 17637173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An optimized automated assay for determination of metabolic stability using hepatocytes: assay validation, variance component analysis, and in vivo relevance.
    Jacobson L; Middleton B; Holmgren J; Eirefelt S; Fröjd M; Blomgren A; Gustavsson L
    Assay Drug Dev Technol; 2007 Jun; 5(3):403-15. PubMed ID: 17638540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro-in vivo correlation for low-clearance compounds using hepatocyte relay method.
    Di L; Atkinson K; Orozco CC; Funk C; Zhang H; McDonald TS; Tan B; Lin J; Chang C; Obach RS
    Drug Metab Dispos; 2013 Dec; 41(12):2018-23. PubMed ID: 23857891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A generic fast solid-phase extraction high-performance liquid chromatography/mass spectrometry method for high-throughput drug discovery.
    Gao L; Cheng X; Zhang J; Burns DJ
    Rapid Commun Mass Spectrom; 2007; 21(21):3497-504. PubMed ID: 17922486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of a high-throughput in vitro alkaline elution/rat hepatocyte assay for DNA damage.
    Gealy R; Wright-Bourque JL; Kraynak AR; McKelvey TW; Barnum JE; Storer RD
    Mutat Res; 2007 Apr; 629(1):49-63. PubMed ID: 17306613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A high-throughput bioanalytical platform using automated infusion for tandem mass spectrometric method optimization and its application in a metabolic stability screen.
    Kieltyka K; Zhang J; Li S; Vath M; Baglieri C; Ferraro C; Zvyaga TA; Drexler DM; Weller HN; Shou WZ
    Rapid Commun Mass Spectrom; 2009 Jun; 23(11):1579-91. PubMed ID: 19399765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Applicability of bioanalysis of multiple analytes in drug discovery and development: review of select case studies including assay development considerations.
    Srinivas NR
    Biomed Chromatogr; 2006 May; 20(5):383-414. PubMed ID: 16307470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.